299 filings
Page 10 of 15
8-K
d8itys9hesceczlq24ti
6 Sep 17
Verastem Expands Duvelisib Development Program to Include Peripheral T-Cell Lymphoma
12:00am
8-K
rck3 levldmgwtg06k60
28 Aug 17
Other Events
12:00am
424B5
mb9zf5fica1diba7z
28 Aug 17
Prospectus supplement for primary offering
12:00am
8-K
bc1dilvelm3nf n2oqh9
11 Jul 17
Verastem Names Julie B. Feder as Chief Financial Officer
12:00am
S-8
1lxv5no1u38sq6o33sp
15 Jun 17
Registration of securities for employees
12:00am
S-8
977d47
15 Jun 17
Registration of securities for employees
12:00am
8-K
u2ebcvh6rk
23 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zb69j
2 May 17
Verastem Appoints Eric K. Rowinsky to the Board of Directors
12:00am
EFFECT
8dymh 2sj6
24 Apr 17
Notice of effectiveness
12:00am
CORRESP
1df2td
20 Apr 17
Correspondence with SEC
12:00am
CT ORDER
uilgggf4szl qje
18 Apr 17
Confidential treatment order
12:00am
CORRESP
qly7fyu0em3z5motje
12 Apr 17
Correspondence with SEC
12:00am
UPLOAD
1i9d3z4lyq
7 Apr 17
Letter from SEC
12:00am
8-K/A
ubjk yw4s
11 Jan 17
Other Events
12:00am